Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
scPharmaceuticals, Inc. (SCPH) had Receiveable Turnover of 3.10 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$36.33M |
|
$-85.15M |
|
$11.36M |
|
$24.97M |
|
$101.11M |
|
$-64.78M |
|
$-20.37M |
|
$-85.15M |
|
$-85.15M |
|
$-85.15M |
|
$-85.15M |
|
$-85.15M |
|
$-85.15M |
|
$-64.78M |
|
$-64.76M |
|
44.52M |
|
44.52M |
|
$-1.91 |
|
$-1.91 |
|
| Balance Sheet Financials | |
$105.85M |
|
$0.06M |
|
$1.67M |
|
$107.52M |
|
$14.88M |
|
$51.35M |
|
$79.32M |
|
$94.20M |
|
$13.32M |
|
$13.32M |
|
$13.32M |
|
50.10M |
|
| Cash Flow Statement Financials | |
$-70.54M |
|
$29.30M |
|
$70.08M |
|
$46.81M |
|
$75.66M |
|
$28.84M |
|
$5.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.12 |
|
-- |
|
-- |
|
0.79 |
|
3.86 |
|
68.73% |
|
-178.29% |
|
-178.29% |
|
-178.23% |
|
-234.36% |
|
-234.36% |
|
$-70.56M |
|
-- |
|
-- |
|
-- |
|
0.34 |
|
0.82 |
|
|
Receiveable Turnover |
3.10 |
117.75 |
|
-639.25% |
|
-639.25% |
|
-79.19% |
|
-131.67% |
|
$0.27 |
|
$-1.58 |
|
$-1.58 |
|